+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 2Months - 75Years
All Genders
ID03016806

Study of Umbilical Cord Blood Transplantation from Unrelated Donors to Treat Blood and Immune Disorders

Led by University of Rochester · Updated on 2025-10-10

30

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the process and outcomes of umbilical cord blood stem cell transplantation from unrelated donors in patients with various blood and immune disorders. The study aims to measure how long it takes for blood cell counts to recover after transplant, how often the transplanted cells fail to engraft, and the rates of disease-free survival, relapse, and graft-versus-host disease GvHD. GvHD is a condition where transplanted white blood cells attack the recipients body. This observational study collects data on patients receiving standard conditioning treatments before transplantation. Participants receive different conditioning treatments based on their medical needs, including full intensity total body irradiation TBI with chemotherapy, full intensity chemotherapy alone, reduced intensity chemotherapy, or non-myeloablative conditioning combining chemotherapy and low-dose TBI. Following conditioning, patients undergo an intravenous infusion of umbilical cord blood stem cells. The specific conditioning regimens vary in drugs and radiation doses, given over several days before the transplant. During the study, medical records are reviewed to monitor engraftment of white blood cells and platelets up to 42 days after transplantation. Researchers track non-engraftment, graft failure, acute and chronic GvHD, disease-free survival, and relapse rates for up to 10 years after transplant. Patients are assessed at regular intervals of 30 days, 100 days, 6 months, and yearly thereafter. The study continues to collect data on these outcomes and overall survival as part of long-term follow-up.

CONDITIONS

Brief Title

Umbilical Cord Blood Transplantation From Unrelated Donors

Research Team

O

Omar Aljitawi, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here